{"denoms":[{"counts":[{"groupId":"BG000","value":"50"}],"units":"Participants"}],"groups":[{"description":"Protocol treatment lasts approximately 52 weeks including a 4-week interim period once radiation therapy is completed and a maintenance phase (cycle duration=28 days).\n\nTreatment directed based on tumor biopsy results requires classification of patients into 1 of 4 potential cohorts: O\\^6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status (negative versus positive) and epidermal growth factor receptor (EGFR) overexpression status (negative versus positive).","id":"BG000","title":"All Biopsied Participants"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"3.3","upperLimit":"17.5","value":"6.3"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"27"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"23"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"50"}]}],"title":"United States"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Region of Enrollment","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"30"}],"title":"MGMT-/EGFR-"},{"measurements":[{"groupId":"BG000","value":"14"}],"title":"MGMT-/EGFR+"},{"measurements":[{"groupId":"BG000","value":"3"}],"title":"MGMT+/EGFR-"},{"measurements":[{"groupId":"BG000","value":"3"}],"title":"MGMT+/EGFR+"}]}],"description":"Treatment directed based on tumor biopsy results requires classification of patients into 1 of 4 potential cohorts: O\\^6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status (negative versus positive) and epidermal growth factor receptor (EGFR) overexpression status (negative versus positive).","paramType":"COUNT_OF_PARTICIPANTS","title":"Molecular Classification","unitOfMeasure":"Participants"}],"populationDescription":"The analysis dataset is comprised of all enrolled participants who underwent stereotactic biopsy."}